medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2023, Number 1

<< Back Next >>

Rev Nefrol Dial Traspl 2023; 43 (1)

Anxiety and depression in the recipient-donor binomial during the kidney transplant protocol

Martínez-Arriaga RJ, Cortés-Sanabria L, Zambrano-Melín JR, Ramírez-Contreras MG, González-Flores CJ, Jalomo-Martínez B, Corona-Rodríguez E, Gómez-Navarro B, Ríos-Rodríguez EP, Ayala-Cortés RA

Language: Spanish
References: 40
Page: 24-37
PDF size: 315.75 Kb.


ABSTRACT

Introduction: Detection of anxiety and depression in the recipient-donor pair (BinRD) during the kidney transplant protocol (KT) is important to establish psychoeducational interventions that help achieve success during and after KT. Objective: To determine the presence of anxiety and depression symptoms in the BinRD during the RT protocol and to identify characteristics and associated factors. Methods: Cross-sectional study, including 174 binomials being evaluated for TR. the Beck Depression Scale (BDI-II) and the Hospital Anxiety and Depression Scale (HADS) were applied at the beginning of the RT protocol. Results: Anxiety and depression symptoms were more frequent in recipient candidates than in donors ([anxiety 39% vs 21%] [depression 46% vs 15%]) (p‹0.0001). The recipients presented a higher risk of depression (OR=4.770, 95% CI 2.854-7.974, p‹0.0001) and anxiety (OR=2.383, 95% CI 1.478-3.841, p‹0.001). Undertaking hemodialysis in private units (OR 0.264, 95%CI 0.106-0.662, p=0.004) or being on automated peritoneal dialysis (OR 0.386, 95%CI 0.173-0.862, p=0.020 was associated with less anxiety in recipients. Conclusions: a high frequency of anxiety and depression symptoms in the BinRD, so it is important to offer efective psychological interventions focused especially on the recipient during the donation evaluation process.


REFERENCES

  1. KDIGO Clinical Practice Guideline on theEvaluation and Management of Candidates forKidney Transplantation. Transplantation 2020;104(Suppl 4): S1-S-98. https://doi.org/10.1097/tp.0000000000003136

  2. KDIGO Clinical Practice Guideline on the Evaluationand Care of Living Kidney Donors. Transplantation2017;101 (Suppl 8): S1-S-106. https://doi.org/10.1097/tp.0000000000001769

  3. Bujan MA, Musa R, Liu WJ, Chew TF, Lim CTS,Morad Z. Depression anxiety and stress among patientswith dialysis and the association with quality of life.Asian Journal of Psychiatry 2015; 18:49-52. https://doi.org/10.1016/j.ajp.2015.10.004

  4. Murtagh FEM, Addington-Hall J, Higginson IJ. The The prevalence of symptoms in end-stage renal disease: asystematic review. Adv Chronic Kidney Dis 2007;14 (1):82–99. https://doi.org/10.1053/j.ackd.2006.10.001

  5. Palmer S, Vecchio M, Craig JC, Tonelli M, JohnsonDW, Nicolucci A, et al. Prevalence of depression inchronic kidney disease: systematic review and metaanalysisof observational studies. Kidney International2013;84 (1): 179-191. https://doi.org/10.1038/ki.2013.77

  6. Pérez-San-Gregorio MA, Martín-Rodríguez A, Luque-Budia A, Conrad R. Concerns, Mental Health, andQuality of Life in Living Kidney Donation–ParentDonor Candidates Worry Less about Themselves.Front Psychol, 2017;8: 564 https://doi.org/10.3389/fpsyg.2017.0056

  7. Holscher CM, Leanza J, Thomas AG, Waldram MM,Haugen CE, Jackson KR, et al. Anxiety, depression,and regret of donation in living kidney donors. BMCNephrol 2018; 19: 218. https://doi.org/10.1186/s12882-018-1024-0

  8. Salud mental. Organización Mundial de la Salud.Disponible en: https://www.who.int/mental_health/es/ (Acceso 12 de diciembre 2021).

  9. GBD 2017 Disease and Injury Incidence and PrevalenceCollaborators. Global, regional, and national incidence,prevalence, and years lived with disability for 354diseases and injuries for 195 countries and territories,1990–2017: a systematic analysis for the Global Burdenof Disease Study 2017. Lancet 2018; 392: 1789–858.https://doi.org/10.1016/S0140-6736(18)32279-7

  10. Plan de acción sobre salud mental, 2013-2020. Organización Mundial de la Salud.Disponible en: https://apps.who.int/iris/bitstream/handle/10665/97488/9789243506029_spa.pdf?sequence=1 (Acceso 18 de febrero 2022).

  11. La Declaración de Estambul. Revista Argentina deTrasplantes 2009; 3: 133-140.

  12. Zigmond AS & Snaith RP. The Hospital Anxiety andDepression Scale. Acta Psychiatr Scand 1983; 67 (6):361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x

  13. Beck AT, Steer RA, Brown GK. BDI-II. BeckDepression Inventory. Manual 2nd Edn. San Antonio, Tx:The Psychological Corporation.

  14. Vázquez C & Sanz J. Fiabilidad y valores normativosde la versión española del inventario para la depresiónde Beck de 1978. Clínica y Salud 1997; 8(3): 403-422.https://psycnet.apa.org/record/1999-13366-001

  15. Galindo VO, Benjet C, Juárez GF, Rojas CE, RiverosRA, Aguilar PJL, et al. Propiedades psicométricasde la Escala Hospitalaria de Ansiedad y Depresión(HADS) en una población de pacientes oncológicosmexicanos.Salud Ment 2015;38 (4): 253-258. https://doi.org/10.17711/sm.0185-3325.2015.035

  16. Yamamoto FJK, Sarmiento AA, García AM, GómezGLE, Toledo MJ, Olivares GL, Fresán OA. Escalade Ansiedad y Depresión Hospitalaria (HADS):Validación en pacientes mexicanos con enfermedadinamatoria intestinal. Gastroenterología y Hepatología2018: 41 (8), 477-482. https://doi.org/10.1016/j.gastrohep.2018.05.009

  17. Orozco NMJ, Pérez TB, Casarrubias VB, García,Robles GR, Sierra MJG. Escala de Ansiedad yDepresión Hospitalaria (HADS): Validación enpacientes mexicanos con infección por VIH.PsicologíaIberoamericana 2013; 21(2), 29-37. https://www.redalyc.org/pdf/1339/133930525004.pdf

  18. González DA, Reséndiz RA, Reyes LI. Adaptationof the BDI-II in México. Salud Mental 2015; 38 (4):237-244. https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDREVISTA=81&IDARTICULO=61062&IDPUBLICACION=6058

  19. Shirazian S, D Grant C, Aina O, Mattana J, KhrorassaniF, Ricardo AC. Depression in Chronic KidneyDisease and End-Stage Renal Disease: Similaritiesand Dierences in Diagnosis, Epidemiology, andManagement. Kidney Int Rep, 2016; 2 (1): 94-107.https://doi.org/10.1016/j.ekir.2016.09.005

  20. Lee MC, Wu SV, Hsieh NC, Tsai JM. Self-Management Programs on eGFR, Depression, andQuality of Life among Patients with Chronic KidneyDisease: A Meta-Analysis. Asian Nurs Res (KoreanSoc Nurs Sci) 2016; 10 (4): 255–262. https://doi.org/10.1016/j.anr.2016.04.002.

  21. De Pasquale C, Pistorio ML, Veroux M, IndelicatoL, Bia G, Bennardi N, et al. Psychological andPsychopathological Aspects of Kidney Transplantation:A Systematic Review. Front Psychiatry 2020; 11: 106.https://doi.org/10.3389/fpsyt.2020.00106

  22. Timmerman L, Laging M, Timman R, Zuidema WC,Beck DK, IJzermans JNM, et al. 2016. The impact ofthe donors’ and recipients’ medical complications onliving kidney donors’ mental health. Transpl Int 2016;29: 589-602. https://doi.org/10.1111/tri.12760

  23. Fischer MJ, Xie D, Jordan N, Kop WJ, Krousel-WoodM, Kurella TM, et al. Factors associated with depressivesymptoms and use of antidepressant medicationsamong participants in the Chronic Renal InsuciencyCohort (CRIC) and Hispanic-CRIC Studies. Am JKidney Dis. 2012;60:27–3 https://doi.org/10.1053/j.ajkd.2011.12.033

  24. Tuot D, Lin F, Norris K, Gassman J, Smogorsewski,Ku E, et al. 2019. Depressive symptoms associate withrace and all-cause mortality in patients with CKD.Kidney Int Rep 2018; 4(2): 222-230. https://doi.org/10.1016/j.ekir.2018.10.001

  25. Sampaio de Brito DC, Leandro ME, Afonso RI,Pires de Freitas DCL, Leal CM. Depression andanxiety among patients undergoing dialysis andkidney transplantation: a cross-sectional study. SaoPaulo Med J 2019; 137 (2): 137-147. https://doi.org/10.1590/1516-3180.2018.0272280119

  26. Fischer MJ, Kimmel PL, Greene T, Gassman JF,Wang X, Brooks DH, et al. Elevated depressive aect isassociated with adverse cardiovascular outcomes amongAfrican Americans with chronic kidney disease. KidneyInt 2011; 80 (6): 670-678. https://doi.org/10.1038/ki.2011.153

  27. Huang CW, Wee PH, Low LL, Koong YLA, Htay H,Fan Q, et al. “Prevalence and risk factors for elevatedanxiety symptoms and anxiety disorders in chronickidney disease: A systematic review and meta-analysis.”General Hospital Psychiatry 2021; 69: 27-40. https://doi.org/10.1016/j.genhosppsych.2020.12.003

  28. Rabindranath KS, Adams, J, Ali TZ, MacLeod AM, ValeL, Cody JD, et al. Continuous ambulatory peritonealdialysis versus automated peritoneal dialysis for endstage renal disease. Cochrane Database of SystematicReviews, 2007 (2) https://doi.org/10.1002/14651858.CD006515

  29. Srifuengfung M, Noppakun K, Srisurapont M.Depression in kidney transplant recipients. Prevalence,risk factors, and association with functional disabilities.J Nerv Ment Dis 2017; 205 (10): 788-792. Doi:10.1097/NMD.0000000000000722

  30. Susuki R, Nakamiya Y, Watanabe M, Ando E, TanichiM, Koga M, et al. Relationship Between Stress CopingMechanisms and Depression in Kidney TransplantRecipients. Transplant Proc 2019; 51 (3): 761-767.https://doi.org/10.1016/j.transproceed.2018.12.034

  31. 31) Czyzewski T, Frelink P, Wyzgal J, Szarpak T. Evaluationof Quality of Life and Severity of Depression, Anxiety,and Stress in Patients After Kidney. Transplant Proc2018; 50 (6): 1733-1737. https://doi.org/10.1016/j.transproceed.2018.04.026

  32. Lin X, Jung L, Liu H, Teng S, Zhang W. Depressivesymptoms and associated factors among renaltransplant recipients in China. Int J Nurs Sci 2016; 3(4):347–353. https://doi.org/10.1016/j.ijnss.2016.11.003

  33. Pascazio L, Nardone IB, Clarici A, Enzmann G,Grignetti M, Panzetta GO, et al. Anxiety, depressionand emotional profile in renal transplant recipients andhealthy subjects: A comparative study. Transplant Proc2010; 42(9): 3586–3590. https://doi.org/10.1016/j.transproceed.2010.08.056

  34. Holscher CM, Leanza J, Tomas AG, Waldram MM,Haugen CE, Jackson KR, et al. Anxiety, depression,and regret of donation in living kidney donors. BMCNephrol 2018; 19 (1):2018. Doi: 10.1186/s12882-018-1024-0. https://doi.org/10.1186/s12882-018-1024-0

  35. Pérez-San-Gregorio MA, Fernández-Jiménez E,Luque-Budia A, Martín-Rodríguez A. Anxiety andconcerns in Spanish living kidney donor candidates. IntJ Psychiatry Med 2015; 50 (2): 163-177. https://doi.org/10.1177/0091217415605031

  36. Wirken L, van Middendorp H, Hooghof CW,Bremer TE, Hopman SPF, van der Pant KAMI, et al.Development and feasibility of a guided and tailoredinternet-based cognitive-behavioural intervention forkidney donors and kidney donor candidates. BMJOpen 2018; 8 (6): e020906. http://dx.doi.org/10.1136/bmjopen-2017-020906

  37. Gheshlagh RG, Sayehmiri K, Ebadi A, Dalvandi A,Dalvand S, Tabrizi KN. Resilience of patients withchronic physical diseases: A systematic review andmeta-analysis. Iran Red Crescent Med J 2016; 18 (7):e38562. https://doi.org/10.5812/ircmj.38562

  38. Bernard P, Romain AJ, Caudroit J, Chevance G,Carayol M, Gourlan, M, et al. Cognitive behaviortherapy combined with exercise for adults with chronicdiseases: Systematic review and meta-analysis. HealthPsychol 2018; 37(5): 433–450. https://doi.org/10.1037/hea0000578

  39. Lerma A, Perez-Grovas H, Bermudez L, Peralta-Pedrero ML, Robles-García R, Lerma C. Briefcognitive behavioural intervention for depression andanxiety symptoms improves quality of life in chronichaemodialysis patients. Psychol Psychother 2017; 90 (1):105–123. https://doi.org/10.1111/papt.12098

  40. Tolin DF, Frost RO, Steketee G, Muro J. Cognitivebehavioral therapy for hoarding disorder: a metaanalysis.Depress Anxiety 2015; 32 (3):158–166. https://doi.org/10.1002/da.22327




2020     |     www.medigraphic.com